A biotech company, Ginkgo Bioworks, has officially opened its office in Melbourne, established by mRNA Victoria. Ginkgo will partner with the local biotech sector to deliver its cell engineering platform.
Read More
Taking Queensland medicine from benchtop to bedside
An additional $35.5 million in funding will support a locally based vaccine manufacturing industry in Queensland via the Translational Research Institute.
Read More
Read More
Government supports production of locally made medicine
Under the Modern Manufacturing Initiative, the federal government has announced $23 million in support for the Australian Precision Medicine Enterprise.
Read More
Read More
$3 million manufacturing capability program supports medtech
A new $3 million Medtech Manufacturing Capability Program has been announced by the Victorian state government to expand local production and aid in fast-tracking manufacturers’ medtech ideas.
Read More
Read More
New device increases detection of wound infection
A new study led by a senior research fellow at the University of Western Australia (UWA) has found fluorescence imaging technology, an advanced diagnostic device which allows clinicians to see into the wound, can increase the detection of infection at a surgical site by 11-fold.
Read More
Read More
mAP grants to support Victorian mRNA manufacturing and R&D
The Victorian government has announced the largest dedicated mRNA research grant program ever seen in Australia, the $21 million mRNA Victoria Activation Program (mAP), to help grow research, development and manufacturing capabilities around the vaccine.
Read More
Read More
Numedico Technologies gains new UAE distribution partnership
Numedico Technologies, an Adelaide-based medical device manufacturer, has announced an estimated $7.48 million distribution partnership with PBC Medicals in the UAE, for their retractable safety syringes – ClickZip.
Read More
Read More
Ginkgo Bioworks to help grow mRNA vaccine capability in Victoria
Synthetic biology company, Ginkgo Bioworks, will establish an office in Melbourne to bolster Victoria’s focus in mRNA research and manufacturing.
Read More
Read More
AirPhysio awarded NSW Exporter of the Year
Tweed Heads-based company AirPhysio, a respiratory health device manufacturer, has been crowned NSW Exporter of the Year at the 2021 Premier’s NSW Export Awards on 24 October.
Read More
Read More
Care Essentials to upscale medical warming blankets manufacture
Care Essentials, a medical manufacturing company based in Geelong, Victoria, is being supported under the Regional Jobs Fund to create 100 new jobs and scale-up the manufacture of their specialised warming blankets.
Read More
Read More
New $96 million RNA pilot manufacturing facility for NSW
NSW is set to lead Australia with a first-of-its-kind pilot facility to develop mRNA and RNA drugs and vaccines, to combat disease and save lives.
Read More
Read More
Safeguarding the future supply of vital nuclear medicines
A new manufacturing facility will be built at Lucas Heights in Sydney as part of a $30 million federal government project to produce vital nuclear medicines.
Read More
Read More
New facility manufactures MedTech prototypes for clinical trials
Neo-Bionica, a new facility opening at St Vincents Hospital, will fast-track the time it takes to develop and trial medical devices, including new treatments for people with diabetes.
Read More
Read More
Driving digital innovation in medical and food manufacturing
The $4 million Faster, Smarter Pharma and Food Manufacturing Project will help drive digital innovation in Victoria’s medicine and food manufacturing industries.
Read More
Read More
Improved treatment under development for leading causes of blindness
Research conducted by University of Queensland UQ Diamantina Institute professor Di Yu has found a potential improved treatment for two of the leading causes of blindness – age and diabetes-related eye problems.
Read More
Read More
Advanced medicinal cannabis products unlocked via new genetic code
Agriculture Victoria scientists have used advanced DNA analysis to unlock the genetic code of medicinal cannabis, enabling more effective health products to be manufactured for people suffering from epilepsy, multiple sclerosis and cancer.
Read More
Read More
Adaptable oxygen conversion unit developed by Monash University
Researchers at Monash University have developed an oxygen conversion unit that can be built from local materials, which will enable doctors to provide life-saving oxygen treatment, particularly in India.
Read More
Read More
BiomeBank submits new microbial therapy for market authorisation
BiomeBank, South Australian biotechnology company, has submitted its world-first biologic drug product to the Therapeutic Goods Administration for market authorisation.
Read More
Read More
Smart wound dressings with healing sensors developed by RMIT
RMIT University researchers have developed smart wound dressings with built-in nanosensors which glow to alert patients when a wound is not healing properly.
The multifunctional, antimicrobial dressings
Read More
Read More
Tape-paper sensor test by Monash could detect jaundice in infants
Monash University researchers have developed a fast, cheap tape-paper sensor test to detect bilirubin in jaundiced newborns, which could be commercialised for point-of-care diagnosis of neonatal jaundice.
The joint
Read More
Read More